Volume 83, Issue 5, Pages (May 2013)

Slides:



Advertisements
Similar presentations
Volume 84, Issue 2, Pages (August 2013)
Advertisements

Beta blockers in the management of chronic kidney disease
Volume 78, Issue 2, Pages (July 2010)
Anemia management in chronic kidney disease
Volume 83, Issue 3, Pages (March 2013)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
C-reactive protein and dialysis access
Volume 84, Issue 3, Pages (September 2013)
Prehypertension and chronic kidney disease: the ox or the plow?
Volume 80, Issue 10, Pages (November 2011)
C-reactive protein and dialysis access
Volume 81, Issue 4, Pages (February 2012)
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Volume 71, Issue 8, Pages (April 2007)
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Steven J. Chadban, Natalie D. Staplin  Kidney International 
Volume 76, Issue 3, Pages (August 2009)
Comorbidity and confounding in end-stage renal disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 81, Issue 3, Pages (February 2012)
Volume 73, Issue 7, Pages (April 2008)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 77, Issue 2, Pages (January 2010)
Volume 86, Issue 2, Pages (August 2014)
Volume 87, Issue 2, Pages (February 2015)
Volume 85, Issue 6, Pages (June 2014)
Blood pressure targets in hemodialysis patients
Volume 82, Issue 1, Pages 3-4 (July 2012)
Volume 78, Issue 8, Pages (October 2010)
Volume 85, Issue 3, Pages (March 2014)
Volume 74, Issue 6, Pages (September 2008)
SYMPLICITY: not all that simple
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
Volume 80, Issue 5, Pages (September 2011)
Alternate-day dialysis may be needed for hemodialysis patients
Volume 87, Issue 1, Pages (January 2015)
Volume 85, Issue 1, Pages 3-4 (January 2014)
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Volume 56, Issue 5, Pages (November 1999)
Volume 71, Issue 12, Pages (June 2007)
Circadian regulation of renal function
Does rituximab help in HLA desensitization for kidney transplantation?
Volume 87, Issue 5, Pages (May 2015)
Volume 76, Issue 8, Pages (October 2009)
Volume 73, Issue 9, Pages (May 2008)
Long-term survival in renal transplant recipients with graft function
Racial differences in survival of patients on dialysis
Organ transplantation goes to the movies
Does equal care give equal outcomes?
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
ANCA comes of age—but with caveats
Volume 71, Issue 9, Pages (May 2007)
Volume 84, Issue 2, Pages (August 2013)
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
American Journal of Kidney Diseases
Volume 82, Issue 9, Pages (November 2012)
The international realities of live donor kidney transplantation
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Global trends in the rates of living kidney donation
Volume 75, Issue 8, Pages (April 2009)
Volume 86, Issue 3, Pages (September 2014)
Daniel L. Roden, Shane T. Grey  Kidney International 
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Volume 83, Issue 5, Pages 775-776 (May 2013) Journal Club    Kidney International  Volume 83, Issue 5, Pages 775-776 (May 2013) DOI: 10.1038/ki.2013.116 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure Kaplan–Meier curve for kidney graft survival by acute rejection phenotype. Initial diagnoses per new approach. Graft survival in patients without rejection is purely illustrative; graft survival in these patients starts at time of transplantation. Abbreviations: TCMR/V–, T cell–mediated rejection without vasculitis; TCMR/V+, T cell–mediated vascular rejection; ABMR/V–,antibody-mediated rejection without vasculitis; ABMR/V+,antibody-mediated vascular rejection. Kidney International 2013 83, 775-776DOI: (10.1038/ki.2013.116) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure Propionate causes a dose-dependent drop in blood pressure in wild-type mice. In Olfr78–/– mice, this response is accentuated at low doses. Kidney International 2013 83, 775-776DOI: (10.1038/ki.2013.116) Copyright © 2013 International Society of Nephrology Terms and Conditions